semaglutide brain effects restores astrocyte–vascular interactions and blood–brain barrier integrity in a model of diet-induced metabolic syndrome | Diabetology & Metabolic Syndrome 12-month neurological and psychiatric outcomes
Description
This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes
Fiber breakdown: Gut bacteria break down fiber into short-chain fatty acids (SCFAs)
Discover why GLP-1 medications like Wegovy and Saxenda can trigger acid reflux, how to manage symptoms effectively, and when to seek medical advice for this common side effect.
New analysis suggests that negotiated pricing still falls short of achieving cost neutrality if GLP-1 drug coverage expands to include weight management.
